10
CSPC Pharma
1093.HK·HKEXShijiazhuang CNFounded 199720,000 employees
Mid CappharmaPublicOncologyCNS
Platform: Innovative
Market Cap
$8B
All Drugs
4
Clinical Trials
10
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (1093.HK)
Loading 1093.HK stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Bemarapivir | 109-1589 | Approved | 4 | CD123 | NMOSDPAH | ||
| 109-1876 | 109-1876 | Preclinical | 2 | WEE1 | DravetSLE | ||
| Rimavorutinib | 109-6321 | Phase 2 | 2 | Aβ | LN | ||
| 109-3699 | 109-3699 | Phase 2 | 2 | GLP-1R | CML |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
CSPC Pharma trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (8)